Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
JAMA Network Open|December 15, 2023
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung CancerTomohiro Sakamoto, Taichi Matsubara, Takayuki Takahama, et al.
Lung Cancer (Amsterdam, Netherlands)|August 11, 2022
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042)Yuji Minegishi, Tomoe Akagami, Makoto Arai, et al.
Oncotarget|January 6, 2017
Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic markerHiroshi Yokouchi, Hiroshi Nishihara, Toshiyuki Harada, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2015
Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A)Hiroshi Yokouchi, Takashi Ishida, Shigeo Yamazaki, et al.
Lab on a Chip|October 25, 2023
High-precision rapid testing of omicron SARS-CoV-2 variants in clinical samples using AI-nanoporeKaoru Murakami, Shimpei I Kubota, Kumiko Tanaka, et al.
Journal of Epidemiology|February 9, 2025
Post COVID-19 condition in hospitalized survivors after one year of infection during the Alpha- and Delta-variant dominant waves in Japan: COVID-19 Recovery Study IIYoko Muto, Mariko Hosozawa, Miyuki Hori, et al.
Oncotarget|January 7, 2017
Expression of Notch1 and Numb in small cell lung cancerHajime Kikuchi, Jun Sakakibara-Konishi, Megumi Furuta, et al.
Lung Cancer (Amsterdam, Netherlands)|January 28, 2021
Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using <sup>125</sup>I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)Hironori Takagi, Songji Zhao, Satoshi Muto, et al.
JTO Clinical and Research Reports|October 24, 2022
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance DataHideki Terai, Kenzo Soejima, Asanao Shimokawa, et al.
Pageof 12